Skip to content

Comparison of Immunization Quality Improvement Dissemination Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02432430
Acronym
CIzQIDS
Enrollment
2186
Registered
2015-05-04
Start date
2013-06-30
Completion date
2014-06-30
Last updated
2015-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chickenpox Vaccine, DTaP Vaccine, Hepatitis B Vaccine, HIB-vaccine, Immunization, MMR Vaccine, Pneumococcal Polysaccharide Vaccine, Poliovirus Vaccine, Inactivated

Keywords

N05.300.150.410, practice guideline, D20.215.894.899.290.130, Health Knowledge, Attitudes, Practice

Brief summary

Dissemination research examines the processes and factors that lead to widespread use of evidence-based interventions. There are several theories on how to best minimize the perceived and actual burdens on practitioners associated with implementing evidence-based medicine. For instance, the pay for performance model attempts to improve physician compliance with quality guidelines by providing financial incentives. Recent studies suggest pay for performance is effective in improving practitioner performance, but it is unclear whether the gains are sustainable once incentives are stopped. Another approach to promoting best practices is the Model for Improvement whose main method is to employ Plan-Do-Study-Act (PDSA) cycles of small changes Although this approach has been successful within individual institutions, there is minimal evidence of its effect when employed simultaneously in multiple autonomous institutions. There is also little evidence of the sustainability of outcomes after intervention activities end. The specific aims of the proposed study are to examine the effect of quality improvement dissemination models on the immunization coverage of children ages 3 to 18 months old. The investigators propose to: 1\. Determine the effect on immunization compliance of two different models of dissemination which will provide physicians 12 months of quality improvement (QI) activity support for implementing CDC immunization best practices. Hypothesis 1a: Study participants receiving the QI technical support intervention (QITS) will have more improvement in immunization rates from baseline to immediately after support ends than participants receiving the pay for performance intervention (P4P). Hypothesis 1b: Study participants receiving QITS will increase immunization coverage for their practices over baseline. Hypothesis 1c: Study participants receiving P4P will increase immunization coverage for their practices over baseline.

Interventions

BEHAVIORALQI support to improve DTP/Hep B/MMR/Var/PCV/Hib/IPV coverage

Quality improvement technical support to help providers' ability to institute best practices to improve delivery of the following vaccines: DTP, HepB, MMR, Var, PCV, Hib, IPV

BEHAVIORALIncentives to improve DTP/HepB/MMR/Var/PCV/Hib/IPV coverage

Financial incentives to support to help providers' ability to institute best practices to improve delivery of the following vaccines: DTP, HepB, MMR, Var, PCV, Hib, IPV

Sponsors

Pfizer
CollaboratorINDUSTRY
Children's National Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Months to 18 Months
Healthy volunteers
Yes

Inclusion criteria

* regular patient of a participating practice

Exclusion criteria

* fewer than 2 encounters at a participating practice * moved or gone elsewhere prior to assessment date * medical contraindication to vaccination

Design outcomes

Primary

MeasureTime frameDescription
relative risk of child being up to date with all age-appropriate vaccines as assessed by random selection of 50 patients per practice for compliance with HepB, DTaP, Hib, PCV, IPV, MMR, Var12 monthsreceipt of all age-appropriate immunization

Secondary

MeasureTime frameDescription
percent of all age-appropriate, indicated vaccines received (HepB, DTaP, Hib, PCV, IPV, MMR, Var)12 monthspercent of all needed vaccines received

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026